Precision BioSciences, Inc.

DTIL · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Operating Activities
Net Income-$21,772-$23,520-$20,565-$17,745
Dep. & Amort.$674$696$705$757
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$2,937$2,822$3,571
Change in WC$1,885-$2,621-$1,295$901
Other Non-Cash$3,943$2,237-$719-$6,167
Operating Cash Flow-$15,270-$20,271-$19,052-$18,683
Investing Activities
PP&E Inv.$0-$17-$64-$97
Net Acquisitions$17$5$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0-$250$0
Investing Cash Flow$17-$12-$314-$97
Financing Activities
Debt Repay.$0$0$0-$20
Stock Issued$1,659$5,300$10,547$5,940
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$0$140$0
Financing Cash Flow$1,659$5,300$10,687$5,920
Forex Effect-$3,778$2$0$0
Net Chg. in Cash-$17,372-$14,981-$8,679-$12,860
Supplemental Information
Beg. Cash$62,242$77,223$108,468$121,328
End Cash$44,870$62,242$99,789$108,468
Free Cash Flow-$15,270-$20,273-$19,366-$18,780
Precision BioSciences, Inc. (DTIL) Financial Statements & Key Stats | AlphaPilot